Pfizer Inc
NYSE: PFE
$24.90
+$0.10 (+0.4%)
Real Time Data Delayed 15 Min.
PFE Articles
These are the top analyst upgrades, downgrades and initiations from select Wall Street research calls on Tuesday, December 3, 2013. They include Apple, 3D Systems, Micron Technology and Tesla Motors.
Published:
ThinkstockThe market for pharmaceuticals and biotech drugs just keeps growing. The so-called patent cliff may be affecting Big Pharma companies locally, but a new report from IMS Health shows that...
Published:
Jon OggWe have now seen the short interest reports from the October 31 settlement date and have compared them to the October 15 settlement date. This is important because it reflects the opinions and...
Published:
Wikimedia CommonsPfizer Inc. (NYSE: PFE) reported third-quarter 2013 results before markets opened Tuesday morning. The drug maker posted adjusted diluted earnings per share (EPS) of $0.58 and...
Published:
Last Updated:
The drug patent cliff for Big Pharma is coming with some continued consequences, and two drug giants with earnings this week are Dow Jones Industrial Average components. Merck & Co. (NYSE: MRK)...
Published:
courtesy of Verizon WirelessMergers and acquisitions (M&A) sometimes can be an excellent measure of the economy’s financial health. However, since there is a great deal of evidence that most...
Published:
Jon OggEarnings season is in full swing and this coming week will bring many key earnings reports. This will also be the last week of major on-calendar earnings for the third quarter, even if...
Published:
Jon OggWe have seen the short interest reports for the October 15 settlement date. It turns out that short sellers have been getting out of the way of the bull market after previously increasing...
Published:
ThinkstockShort sellers have increased their bets against the stable high-dividend stocks that are in most Americans’ retirement accounts and mutual funds. The end-of-September short interest saw...
Published:
ThinkstockThe drug and pharmaceutical sector is supposed to be a defensive one by nature, even if this week’s government shutdown and impending debt ceiling weighed heavily on biotech stocks....
Published:
ThinkstockWhen the markets go through periods of great gains, it is not uncommon to see companies start to take more radical efforts to increase their total return for shareholders. Some may go...
Published:
ThinkstockMerck & Co. (NYSE: MRK) announced it would rid itself of 8,500 workers, many of whom work in the big pharmaceutical company’s R&D operations. Since the return on research...
Published:
via Wikimedia CommonsIt looks like Congress and the president still cannot figure out how to play well with each other, and now we have another impending government shutdown. The reality is that some...
Published:
ThinkstockShort sellers have increased their bets against the stable high-dividend stocks that are in most Americans’ retirement accounts and mutual funds. In fact, the mid-September short interest...
Published:
Wikimedia CommonsChances are high that you already have heard that the Dow Jones Industrial Average (DJIA) is making a serious change among its 30 constituents. What you might not have heard outside...
Published: